SMARCB1-deficient cancers: novel molecular insights and therapeutic vulnerabilities

GW Cooper, AL Hong - Cancers, 2022 - mdpi.com
Simple Summary Loss of SMARCB1 has been identified as the sole mutation in a number of
rare pediatric and adult cancers, most of which have a poor prognosis despite intensive …

Artificial intelligence for precision oncology

S Bhalla, A Laganà - Computational methods for precision oncology, 2022 - Springer
Precision oncology is an innovative approach to cancer care in which diagnosis, prognosis,
and treatment are informed by the individual patient's genetic and molecular profile. The …

[HTML][HTML] Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor

E Alva, J Rubens, S Chi, T Rosenberg, A Reddy… - Neoplasia, 2023 - Elsevier
Atypical teratoid rhabdoid tumors (AT/RT) are malignant central nervous system (CNS)
tumors that occur mostly in young children and have historically carried a very poor …

Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics

PD Johann, L Altendorf, EM Efremova, T Holsten… - Acta …, 2023 - Springer
Atypical teratoid/rhabdoid tumors (AT/RT) are the most common malignant brain tumors
manifesting in infancy. They split into four molecular types. The major three (AT/RT-SHH …

Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center …

APY Liu, SK Dhanda, T Lin, E Sioson, A Vasilyeva… - Acta …, 2022 - Springer
Methylation profiling has radically transformed our understanding of tumors previously
called central nervous system primitive neuro-ectodermal tumors (CNS-PNET). While this …

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities

I Paassen, J Williams, C Ríos Arceo, F Ringnalda… - Oncogene, 2023 - nature.com
Atypical teratoid/rhabdoid tumors (ATRTs) represent a rare, but aggressive pediatric brain
tumor entity. They are genetically defined by alterations in the SWI/SNF chromatin …

Atypical teratoid rhabdoid tumor: proposal of a diagnostic pathway based on clinical features and neuroimaging findings

R Calandrelli, L Massimi, F Pilato, T Verdolotti… - Diagnostics, 2023 - mdpi.com
Purpose: To assess the main imaging and clinical features in adult-and pediatric-onset
atypical teratoid rhabdoid tumor (ATRT) in order to build a predefined pathway useful for the …

Children's Oncology Group's 2023 blueprint for research: central nervous system tumors

SES Leary, A Onar‐Thomas, J Fangusaro… - Pediatric Blood & …, 2023 - Wiley Online Library
Tumors of the central nervous system (CNS) are a leading cause of morbidity and mortality
in the pediatric population. Molecular characterization in the last decade has redefined CNS …

Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor

SA Upadhyaya, O Campagne, CA Billups… - Neuro …, 2023 - academic.oup.com
Background Recurrent atypical teratoid/rhabdoid tumor (AT/RT) is, most often, a fatal
pediatric malignancy with limited curative options. Methods We conducted a phase II study …

DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts

QT Tran, SA Upadhyaya, CA Billups… - Acta …, 2023 - Springer
Atypical teratoid/rhabdoid tumors (ATRT) are malignant embryonal tumors, most often
presenting in children under three years of age [7]. Three consensus ATRT molecular …